Avangio Injection
Marketer
PlasmaGen Biosciences Pvt Ltd
Salt Composition
Bevacizumab (400mg)
Overview Avangio Injection
Bevacizumab injection is a cancer treatment used for colorectal, non-small cell lung, kidney, brain, ovarian, and cervical cancers. Its mechanism involves inhibiting tumor angiogenesis, thereby restricting tumor growth. Highly effective as a first-line therapy in conjunction with other anticancer agents, it's administered intravenously via infusion, either directly into a vein or through a surgically implanted port. Dosage and treatment duration are determined by your physician, who will monitor for infusion reactions like hypertension and respiratory distress. Continued use depends on disease response and tolerability of side effects, with discontinuation decided by your doctor. Regular monitoring of blood pressure and urinary protein levels may be advised. Common side effects include rectal hemorrhage, altered taste perception, and cephalalgia. Preoperative disclosure to your surgeon is crucial due to its potential to impair wound healing. Increased bleeding risk necessitates immediate medical attention for any unusual bleeding. Disclose current pregnancies, pregnancy intentions, or breastfeeding to your physician. Comprehensive medication disclosure to your healthcare provider is imperative due to potential drug interactions.
Uses of Avangio Injection
Colorectal, ovarian, cervical, and kidney cancers; brain tumors; non-small cell lung carcinoma.
Major Benefits of Avangio Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Avangio Injection:
- Exfoliative dermatitis
- High blood pressure
- Nosebleeds
- Protein in urine
- Decreased appetite
- Electrolyte imbalance
- Peripheral sensory neuropathy
- Breathlessness
- Thromboembolism
- Wound healing complications
- Ovarian failure
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Mucosal inflammation
- Abscess
- Cellulitis
- Hypersensitivity
- Rectovaginal fistula
How to use Avangio Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Avangio Injection works:
Avangio Injection is an anti-angiogenesis therapy. Its mechanism of action involves inhibiting vascular endothelial growth factor (VEGF), a protein crucial for blood vessel development. This blockage deprives cancerous tumors of the oxygen and nutrients supplied via newly formed blood vessels.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Avangio Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Avangio Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Avangio Injection while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Avangio Injection may induce adverse reactions that could compromise driving safety. Reported side effects include drowsiness and syncope, potentially affecting driving capabilities.
KidneySAFE IF PRESCRIBED
Avangio Injection appears to pose minimal risk for individuals with kidney impairment. Preliminary findings indicate that dosage modification may be unnecessary in this population. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Avangio Injection in patients with liver disease appears to pose minimal risk. Existing evidence indicates that dose modification is likely unnecessary for this patient group. However, physician consultation is recommended.
What if you forget to take Avangio Injection :
Omitting a scheduled dose of Avangio Injection warrants immediate physician consultation.
Facts to Know About Avangio Injection
| Label | Value |
|---|---|
| Chemical Classification | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | VEGF inhibitor |
3,018 People bought this recently